Canine bone marrow-derived mesenchymal stem cells represent a potential starting source for the in vitro generation of functional insulin-producing cells that can be used in the clinical setting for treating diabetes mellitus type 1 in humans and dogs. Here, INS is linked to diabetes mellitus.